Lixisenatide is effective and well tolerated in patients with type 2 diabetes mellitus and renal impairment

被引：0
|
作者：
Hanefeld, M. [1 ]
Ambos, A. [2 ]
Arteaga, J. [3 ]
Leiter, L. A. [4 ]
Marchesini, G. [5 ]
Nikonova, E. [6 ]
Shestakova, M. [7 ]
Stager, W. [8 ]
Tambascia, M. [9 ]
Gomez Huelgas, R. [10 ]
机构：
[1] GWT TUD GmbH, Study Ctr Prof Hanefeld, Dresden, Germany
[2] North Estonia Med Ctr, Tallinn, Estonia
[3] Univ Nacl Colombia, Sch Med, Bogota, Colombia
[4] Univ Toronto, St Michaels Hosp, Toronto, ON M5S 1A1, Canada
[5] Univ Bologna, I-40126 Bologna, Italy
[6] Sanofi, Diabet Div, Global Med Afairs, Bridgewater, MA USA
[7] Endocrinol Res Ctr, Moscow, Russia
[8] Sanofi, Diabet Div, Bridgewater, MA USA
[9] Univ Estadual Campinas, Campinas, SP, Brazil
[10] Univ Reg Hosp, Malaga, Spain
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
841
引用
收藏
页码：S341 / S342
页数：2
相关论文
共 50 条
  • [21] ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SEVERE RENAL IMPAIRMENT: AN UPDATE
    Aperis, Georgios
    JOURNAL OF RENAL CARE, 2012, 38 (03) : 170 - 171
  • [22] Auditory impairment in patients with type 2 diabetes mellitus
    de León-Morales, LVD
    Jáuregui-Renaud, K
    Garay-Sevilla, ME
    Hernández-Prado, J
    Malacara-Hernández, JM
    ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) : 507 - 510
  • [23] The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel
    Miossec, Patrick
    Larsen, Bjarne Due
    Werner, Ulrich
    Knop, Filip K.
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (10) : 1223 - 1251
  • [24] Estimated Prevalence of Renal Impairment among Patients with Type 2 Diabetes Mellitus in the United States
    Johnston, Stephen
    Sheehan, John
    Riehle, Ellen
    Cappell, Katherine
    Varker, Helen
    Anzalone, Deborah
    Ghannam, Ameen
    Kalsekar, Iftekhar
    DIABETES, 2015, 64 : A71 - A71
  • [25] Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment
    Zhao, Hengli
    Zhao, Zhirui
    He, Kun
    Mi, Nianrong
    Lou, Kai
    Dong, Xiaolin
    Zhang, Wenyu
    Sun, Jingfang
    Hu, Xinyu
    Pang, Shuguang
    Cheng, Hong
    Wen, Qing
    CLINICAL PHARMACOKINETICS, 2023, 62 (08) : 1093 - 1103
  • [26] Hypoglycaemia in patients with diabetes mellitus and renal impairment
    Hettige, Thushan S.
    Cooper, Mark E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (02): : 166 - 168
  • [27] Sleep-disordered breathing is correlated to renal impairment in patients with diabetes mellitus type 2
    Stadler, Stefan
    Zimmermann, Tanja
    Rheinberger, Myriam
    Boeger, Carsten
    Arzt, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [28] Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment
    Hengli Zhao
    Zhirui Zhao
    Kun He
    Nianrong Mi
    Kai Lou
    Xiaolin Dong
    Wenyu Zhang
    Jingfang Sun
    Xinyu Hu
    Shuguang Pang
    Hong Cheng
    Qing Wen
    Clinical Pharmacokinetics, 2023, 62 : 1093 - 1103
  • [29] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Fioretto, Paola
    Stefansson, Bergur V.
    Johnsson, Eva
    Cain, Valerie A.
    Sjostrom, C. David
    DIABETOLOGIA, 2016, 59 (09) : 2036 - 2039
  • [30] Vildagliptin is safe and well tolerated in patients with mild or moderate renal impairment
    Thuren, T.
    Byiers, S.
    Mohideen, P.
    DIABETOLOGIA, 2007, 50 : S363 - S364
12345